These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10227445)

  • 1. Gamma camera imaging of platinum in tumours and tissues of patients after administration of 191Pt-cisplatin.
    Areberg J; Björkman S; Einarsson L; Frankenberg B; Lundqvist H; Mattsson S; Norrgren K; Scheike O; Wallin R
    Acta Oncol; 1999; 38(2):221-8. PubMed ID: 10227445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorbed doses to patients from 191Pt-, 193mPt- and 195mPt-cisplatin.
    Areberg J; Norrgren K; Mattsson S
    Appl Radiat Isot; 1999 Nov; 51(5):581-6. PubMed ID: 10464923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamma camera scintigraphy of tumours using (195m)Pt-cisplatin.
    Buckley SE; Ali PA; Evans CJ; El-Sharkawi AM
    Phys Med Biol; 2006 Mar; 51(5):1325-32. PubMed ID: 16481697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variations in tumor levels of cis-platinum through a course of fractionated radiotherapy in patients with non-small cell lung cancer.
    Minatel E; Trovo MG; Ward R; Gobitti C; Mazza F; Franchin G; Bujor L; Zanelli GD
    Tumori; 1997; 83(6):904-6. PubMed ID: 9526581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue platinum after clinical treatment with cisplatin or carboplatin in tumor-bearing patients.
    Minami T; Tohno Y; Tohno S; Utsumi M; Yamada M; Hashii K; Tateyama I; Kadota E; Okazaki Y
    Biol Trace Elem Res; 1997; 58(1-2):77-83. PubMed ID: 9363322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake and retention of platinum in patients undergoing cisplatin therapy.
    Jonson R; Börjesson J; Mattsson S; Unsgaard B; Wallgren A
    Acta Oncol; 1991; 30(3):315-9. PubMed ID: 2036240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor effect of radioactive cisplatin (191Pt) on nude mice.
    Areberg J; Wennerberg J; Johnsson A; Norrgren K; Mattsson S
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):827-32. PubMed ID: 11172966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of platinum concentrations in human head and neck tumours following administration of carboplatin, iproplatin or cisplatin.
    Hecquet B; Caty A; Fournier C; Lefebvre JL; Adenis L
    Bull Cancer; 1987; 74(4):433-6. PubMed ID: 3311237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumoral platinum concentrations in patients treated with repeated low-dose cisplatin as a radiosensitizer.
    Lagrange JL; Bondiau PY; Tessier E; Chauvel P; Renée N; Etienne MC; Milano G
    Int J Cancer; 1996 Nov; 68(4):452-6. PubMed ID: 8945615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting platinum concentrations in human surgical tumour specimens after cisplatin.
    Stewart DJ; Molepo JM; Green RM; Montpetit VA; Hugenholtz H; Lamothe A; Mikhael NZ; Redmond MD; Gadia M; Goel R
    Br J Cancer; 1995 Mar; 71(3):598-604. PubMed ID: 7880744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy.
    Bonetti A; Apostoli P; Zaninelli M; Pavanel F; Colombatti M; Cetto GL; Franceschi T; Sperotto L; Leone R
    Clin Cancer Res; 1996 Nov; 2(11):1829-35. PubMed ID: 9816137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetic analysis of cisplatin and its metabolites in cancer patients: possible misinterpretation of covariates for pharmacokinetic parameters calculated from the concentrations of unchanged cisplatin, ultrafiltered platinum and total platinum.
    Hanada K; Nishijima K; Ogata H; Atagi S; Kawahara M
    Jpn J Clin Oncol; 2001 May; 31(5):179-84. PubMed ID: 11450990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An autoradiographic study of the intrarenal localisation and retention of cisplatin, iproplatin and paraplatin.
    Ewen C; Perera A; Hendry JH; McAuliffe CA; Sharma H; Fox BW
    Cancer Chemother Pharmacol; 1988; 22(3):241-5. PubMed ID: 3044632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin.
    Meerum Terwogt JM; Groenewegen G; Pluim D; Maliepaard M; Tibben MM; Huisman A; ten Bokkel Huinink WW; Schot M; Welbank H; Voest EE; Beijnen JH; Schellens JM
    Cancer Chemother Pharmacol; 2002 Mar; 49(3):201-10. PubMed ID: 11935212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microscale syntheses of anti-tumour platinum compounds labelled with 191Pt.
    Baer J; Harrison R; McAuliffe CA; Zaki A; Sharma HL; Smith AG
    Int J Appl Radiat Isot; 1985 Mar; 36(3):181-4. PubMed ID: 3888854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of platinum in saliva of patients treated with cisplatin.
    Holding JD; Lindup WE; Roberts NB; Salvatori P; Stell PM
    Ann Clin Biochem; 1999 Sep; 36 ( Pt 5)():655-9. PubMed ID: 10505218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole body retention in rats of different 191Pt compounds following inhalation exposure.
    Moore W; Malanchuk M; Crocker W; Hysell D; Cohen A; Stara JF
    Environ Health Perspect; 1975 Dec; 12():35-9. PubMed ID: 1227859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative renal, hepatic, and bone marrow toxicity of Cisplatin and radioactive Cisplatin (191Pt) in Wistar rats.
    Norrgren K; Sjölin M; Björkman S; Areberg J; Johnsson A; Johansson L; Mattsson S
    Cancer Biother Radiopharm; 2006 Oct; 21(5):528-34. PubMed ID: 17105425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of platinum in human gynecologic tissues and pelvic lymph nodes after administration of cisplatin.
    Tokuhashi Y; Kikkawa F; Ishikawa H; Tamakoshi K; Hattori S; Matsuzawa K; Inoue T; Suganuma N; Tomoda Y
    Gynecol Obstet Invest; 1997; 44(4):270-4. PubMed ID: 9415527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo distribution studies of radioactively labelled platinum complexes; cis-dichlorodiammine platinum(II), cis-trans-dichlorodihydroxy-bis-(isopropylamine) platinum(IV), cis-dichloro-bis-cyclopropylamine platinum(II), and cis-diammine 1,1-cyclobutanedicarboxylate platinum(II) in patients with malignant disease, using a gamma camera.
    Owens SE; Thatcher N; Sharma H; Adam N; Harrison R; Smith A; Zaki A; Baer JC; McAuliffe CA; Crowther D
    Cancer Chemother Pharmacol; 1985; 14(3):253-7. PubMed ID: 3888431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.